Trial intelligence / Profile preview

Imported Probucol in Hyperlipidemia

NCT01349010Phase 3Completed

Sponsor
Otsuka Holdings
Start
Apr 2011
Primary completion
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of probucol in hyperlipidemia, sponsored by Otsuka Holdings. Started Apr 2011; status: completed.

02

Drugs

probucol
03

Conditions

hyperlipidemia

Beyond the preview

Go deeper on NCT01349010.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01349010.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call